A carregar...
Chlorpromazine versus piperacetazine for schizophrenia
BACKGROUND: Schizophrenia is a severe mental disorder with a prevalence of about 1% among the general population. It is listed among the top 10 causes of disability‐adjusted life years (DALYs) worldwide. Antipsychotics are the mainstay treatment. Piperacetazine has been reported to be as clinically...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2018
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517193/ https://ncbi.nlm.nih.gov/pubmed/30378678 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011709.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|